Table 2.
Outcome of mild disease patients after the first 2 years of study entry
| n (%) | |
| Starting immunomodulator | 8 (27.6) |
| Starting biologic | 0 |
| Starting immunomodulator and biologic | 0 |
| Surgery | 0 |
| Continued on minimal therapy | 21 (72.4) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.